Biogen Idec to Present at the 2013 RBC Capital Markets Global Healthcare Conference
Biogen Idec to Present at the 2013 RBC Capital Markets Global Healthcare Conference
WESTON, Mass.--(BUSINESS WIRE)-- Biogen Idec Inc. (NAS: BIIB) announced today that it will present at the 2013 RBC Capital Markets Global Healthcare Conference. The webcast will be live on Tuesday, February 26, 2013 at 9:30 a.m. ET. To access the live webcast, please visit Biogen Idec's Investors section at www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.
Investor Relations
Biogen Idec
Karen Jewell, 781-464-2442
KEYWORDS: United States North America Massachusetts New Mexico
INDUSTRY KEYWORDS:
The article Biogen Idec to Present at the 2013 RBC Capital Markets Global Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
